Supercharge Your Innovation With Domain-Expert AI Agents!

Allicin preparation for treating coronavirus infection and related symptoms thereof

A coronavirus and allicin technology, applied in the field of allicin preparations, can solve the problems of long cycle, individual differences, high price, etc.

Pending Publication Date: 2022-02-18
肖军宏
View PDF2 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] In the past few decades, diseases caused by coronaviruses have posed a huge threat to global public health, such as acute respiratory syndrome virus (SARS), Middle East respiratory syndrome virus (MERS) and the emergence of new coronaviruses ( 2019-nCoV), etc. Lung diseases caused by coronavirus infection are often followed by complications of varying degrees, especially elderly patients and those with chronic underlying diseases have poor prognosis, long cycle, and individual differences;
[0003] As a drug that has been clinically used for many years, allicin has the characteristics of extensive pharmacological effects, definite curative effect, safety and no side effects. At present, the preparations for the treatment of coronavirus infection and related symptoms have relatively large side effects and are expensive. The effect of related symptoms is not good, which brings great difficulties to the treatment of coronavirus infection and its related symptoms

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Allicin preparation for treating coronavirus infection and related symptoms thereof
  • Allicin preparation for treating coronavirus infection and related symptoms thereof
  • Allicin preparation for treating coronavirus infection and related symptoms thereof

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0026] A preparation method of an allicin preparation for the treatment of coronavirus infection and related symptoms thereof, comprising the following steps:

[0027] S1, configuration solution 1: according to the formula ratio, weigh chloroquine phosphate and arbidol hydrochloride, add chloroquine phosphate to the ethanol of the formula ratio, put it in the container for stirring treatment, the stirring time is 2-10min, after the stirring is completed, Continue to add Arbidol hydrochloride into the container, continue to stir, the stirring time is 5-20min, after stirring evenly, let it stand for 10-60min;

[0028] S2, configuration solution 2: according to the formula ratio, weigh the immunoglobulin, glucocorticoid, and lecithin, add the immunoglobulin, glucocorticoid, and lecithin into the water of the formula ratio, and place it in the container for stirring. Stirring time is 1-4min, after stirring evenly, let stand for 4-20min;

[0029] S3. Mixed solution: according to t...

Embodiment 1

[0032] Embodiment 1, a kind of allicin preparation for the treatment of coronavirus infection and related symptoms thereof, each component is calculated by its mass percentage: allicin: 40%, emodin: 27%, water: 5%, ethanol: 4% , Chloroquine Phosphate: 6%, Interferon: 2%, Arbidol Hydrochloride: 2%, Immunoglobulin: 2%, Glucocorticoids: 1.5%, Theophylline: 2.5%, Cyclosporine: 2%, Nafal Azolone: ​​1%, probiotic powder: 1%, lecithin: 2%, polyoxyethylene fatty acid ester: 2%.

[0033]

[0034] A preparation method of an allicin preparation for the treatment of coronavirus infection and related symptoms thereof, comprising the following steps:

[0035] S1, configuration solution 1: according to the formula ratio, weigh chloroquine phosphate and arbidol hydrochloride, add chloroquine phosphate into the ethanol of the formula ratio, place it in the container for stirring, the stirring time is 10min, after the stirring is completed, continue to add Add Arbidol hydrochloride into the...

Embodiment 2

[0040] Embodiment 2, a kind of allicin preparation for the treatment of coronavirus infection and related symptoms thereof, each component is calculated by its mass percentage: allicin: 15%, emodin: 20%, water: 17%, ethanol: 10% , Chloroquine Phosphate: 10%, Interferon: 6%, Arbidol Hydrochloride: 5%, Immunoglobulin: 2.5%, Glucocorticoids: 3%, Theophylline: 2.5%, Cyclosporine: 2%, Nafal Azolone: ​​2%, probiotic powder: 1%, lecithin: 2%, polyoxyethylene fatty acid ester: 2%.

[0041]

[0042]A preparation method of an allicin preparation for the treatment of coronavirus infection and related symptoms thereof, comprising the following steps:

[0043] S1, configuration solution 1: according to the formula ratio, weigh chloroquine phosphate and arbidol hydrochloride, add chloroquine phosphate to the ethanol of the formula ratio, place it in the container for stirring, the stirring time is 2min, after the stirring is completed, continue to add Add Arbidol hydrochloride into the ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an allicin preparation for treating coronavirus infection and related symptoms thereof. The allicin preparation is prepared from the following components in percentage by mass: 1%-40% of allicin, 1%-35% of emodin, 1%-30% of water, 1%-10% of ethanol, 1%-10% of an inhibitor, 1%-6% of an interferon, 1%-5% of an antiviral agent, 0.5%-3% of immune globulin, 1%-3% of a modifier, 1%-2.5% of theophylline, 1%-2% of cyclosporin, 1%-2% of nefazodone, 1%-2% of probiotic powder, 1%-2% of a stabilizer and 1%-2% of a surfactant. The allicin preparation has the advantages that allicin and emodin are added, the allicin and the emodin are mixed and jointly treat coronavirus infection and related symptoms of the coronavirus infection, and the treatment effect is improved; and the modifier is added, the modifier is glucocorticoid, and the anti-inflammatory effect of the medicine is improved.

Description

technical field [0001] The invention relates to the technical field of allicin preparations, in particular to an allicin preparation for treating coronavirus infection and related symptoms. Background technique [0002] In the past few decades, diseases caused by coronaviruses have posed a huge threat to global public health, such as acute respiratory syndrome virus (SARS), Middle East respiratory syndrome virus (MERS) and the emergence of new coronaviruses ( 2019-nCoV), etc. Lung diseases caused by coronavirus infection are often followed by complications of varying degrees, especially elderly patients and those with chronic underlying diseases have poor prognosis, long cycle, and individual differences; [0003] As a drug that has been clinically used for many years, allicin has the characteristics of extensive pharmacological effects, definite curative effect, safety and no side effects. At present, the preparations for the treatment of coronavirus infection and related s...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K45/00A61K31/255A61K31/122A61K47/24A61K47/44A61K47/36A61K47/32A61P31/14A61K31/573A61K31/4706A61K31/4045A61K31/7056A61K31/522A61K39/395A61K38/13A61K35/741
CPCA61K45/00A61K31/255A61K31/122A61K31/573A61K31/4706A61K31/4045A61K31/7056A61K39/395A61K31/522A61K38/13A61K35/741A61K47/24A61K47/44A61K47/36A61K47/32A61P31/14A61K2300/00
Inventor 肖军宏肖晓
Owner 肖军宏
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com